Nasdaq:US$13.77 (+0.25) | HKEX:HK$20.72 (+0.00) | AIM:£1.97 (+0.04)
News & Presentations
Previous Article   |   Next Article
Presentations, Scientific Publications | 6 Apr 2011

AACR 2011: Savolitinib (HMPL-504) against subcutaneous xenograft and orthotopic brain tumor models